Keywords: popularity, otc, allergy, products, puts, pressure, rx
Popularity of OTC allergy products puts pressure on US Rx prices
Article | 26 January 2004
In the USA, modified health care coverage, with increased co-payments and other disincentives, is decreasing demand for high-priced prescription products ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
